CLINICAL_TRIALS
trial_result
· 2021-01-22
Clinical Trial Update: Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma [Phase 2]
Summary
Phase II trial of PI-88 in combination with dacarbazine for metastatic melanoma completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cellxpert Biotechnology Corp. | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2021-01-22